Metraipolis › archive › dc_4e69bb3e4594

The efficacy and safety of sacituzumab govitecan in the treatment of breast cancer: a systemic review and meta-analysis of emerging clinical data — Europe PMC PMID:41280925

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41280925
DOI: 10.3389/fimmu.2025.1683594
License (as archived): solo-consultazione
Archived: 2026-11-08T18:04:12.113Z
SHA-256 of the archived text: 59411ae0064750c45a2a7d77a120525b2122546637c1e2c493012f72561cf311
Stable URL of this page: https://metraipolis.com/documento/dc_4e69bb3e4594

How to cite

The efficacy and safety of sacituzumab govitecan in the treatment of breast cancer: a systemic review and meta-analysis of emerging clinical data — Europe PMC PMID:41280925 — Europe PMC (en), https://europepmc.org/article/MED/41280925 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e69bb3e4594 (Metraipolis archive dc_4e69bb3e4594, sha256 59411ae0064750c45a2a7d77a120525b2122546637c1e2c493012f72561cf311)

BibTeX

@misc{dc4e69bb3e4594,
  title = {The efficacy and safety of sacituzumab govitecan in the treatment of breast cancer: a systemic review and meta-analysis of emerging clinical data — Europe PMC PMID:41280925},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41280925},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e69bb3e4594; sha256 59411ae0064750c45a2a7d77a120525b2122546637c1e2c493012f72561cf311},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41280925. Agents can read the archived copy with the MCP tool read_document.